Key Facts About Medicare Spending Trends and Projections from the 2026 Medicare Trustees Report
On June 9, 2026, the Medicare Trustees issued the annual report on the financial status of the Medicare program for...
How Medicare Advantage Rebates Disadvantage Medicare’s Stand-Alone Drug Plan Market
The Medicare Part D prescription drug benefit was designed to offer Medicare beneficiaries the choice of drug coverage from either...
Medicare Part D Enrollment, Premiums, and Cost Sharing in 2026
The average monthly premium decreased for PDPs in 2026, but the premium for Part D coverage is still substantially higher...
Key Facts About Health Care Affordability for People With Medicare
This brief draws on data from various sources. Data on income and savings of Medicare beneficiaries, including the share of...
What to Know About the BALANCE Model for GLP-1s in Medicare and Medicaid
Editorial Note On April 21, 2026, CMS announced that the BALANCE Model will not be implemented in Medicare Part D...
A look at Part D enrollment trends for 2026
Just over 56 million people are enrolled in Medicare Part D, with the share of those securing coverage through Medicare...
Recent Trends in GLP-1 Use and Spending in Medicare
Ahead of the Trump administration’s planned expansion of Medicare coverage for GLP-1s to treat obesity through temporary models and the...
CMMI proposes new models to lower drug prices in Parts B, D
The Medicare Innovation Center has proposed two drug pricing models that would lower the cost of certain drugs to reflect...
What to Know About Pharmacy Benefit Managers (PBMs) and Federal Efforts at Regulation
The price of prescription drugs in the U.S. continues to be a concerning issue to the public, with KFF polling...
CMS launching payment model to boost access to GLP-1s
The Trump administration has unveiled yet another new payment model, this one focused on the cost of GLP-1 therapies. The...
